These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2439573)

  • 1. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
    Müller R; Klein H; Vido I; Niehoff G; Lautz HU; Gebel M; Schmidt FW
    J Hepatol; 1986; 3 Suppl 2():S217-23. PubMed ID: 2439573
    [No Abstract]   [Full Text] [Related]  

  • 2. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
    JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic viral hepatitis.
    de Man RA; Berk L; Schalm SW; Stijnen T
    Dig Dis; 1991; 9(1):17-35. PubMed ID: 1706968
    [No Abstract]   [Full Text] [Related]  

  • 6. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
    Brook MG; Petrovic L; McDonald JA; Scheuer PJ; Thomas HC
    J Hepatol; 1989 Mar; 8(2):218-25. PubMed ID: 2469711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
    Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
    J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
    Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
    Perrillo RP
    J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV
    J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
    Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 16. A statistical view of clinical trials in chronic hepatitis B.
    Burke CA
    J Hepatol; 1986; 3 Suppl 2():S261-7. PubMed ID: 2439574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
    La Banda F; Ruiz Moreno M; Carreño V; Bartolome J; Gutiez J; Ramon y Cajal S; Moreno A; Mora I; Carlos Porres J
    Lancet; 1988 Jan; 1(8579):250. PubMed ID: 2893078
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic hepatitis caused by hepatitis B virus].
    Ouzan D
    Rev Prat; 1990 May; 40(14):1298-300. PubMed ID: 1694296
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
    Esteban R; Buti M; Vallés M; Allende H; Guardia J
    Hepatology; 1986; 6(4):762-3. PubMed ID: 2426174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.